JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Price:
1.82 HKD
-1.09%
Updated:
May 9, 2024
JW (Cayman) Therapeutics Co Ltd
Operating Expenses
|
JW (Cayman) Therapeutics Co Ltd
Operating Expenses Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Operating Expenses
-¥695.7m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Operating Expenses
-¥19.7B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Expenses
-¥6.1B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Expenses
-¥3.1B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Expenses
-¥4.6B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-33%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Expenses
-¥458.8m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Operating Expenses?
Operating Expenses
-695.7m
CNY
-695.7m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Operating Expenses amounts to -695.7m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-43%
-43%
Over the last year, the Operating Expenses growth was 8%. The average annual Operating Expenses growth rates for JW (Cayman) Therapeutics Co Ltd have been -14% over the past three years , -43% over the past five years .
You don't have any saved screeners yet
